Clinical trials
Immunoglobulin G4-Related Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
69 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 5 |
| 2015 | 2 |
| 2016 | 5 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 7 |
| 2024 | 11 |
| 2025 | 11 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 21 |
| Unknown status | 17 |
| Not yet recruiting | 12 |
| Completed | 11 |
| Active, not recruiting | 5 |
| Terminated | 1 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking Union Medical College Hospital | 14 |
| Chinese PLA General Hospital | 3 |
| Meir Medical Center | 3 |
| Tongji Hospital | 3 |
| Wen Zhang | 3 |
| Amgen | 2 |
| Assistance Publique Hopitaux De Marseille | 2 |
| Changhai Hospital | 2 |
| Mayo Clinic | 2 |
| Peking University People's Hospital | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immunoglobulin G4-Related Disease | 69 |
| Autoimmune Diseases | 9 |
| Lupus Erythematosus, Systemic | 8 |
| Myositis | 8 |
| Recurrence | 7 |
| Scleroderma, Systemic | 7 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 6 |
| Arthritis, Rheumatoid | 5 |
| Lupus Nephritis | 4 |
| Sjogren's Syndrome | 3 |
Trials
Showing 1 to 25 of 69. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.